SCHEMBL14447296

SCHEMBL14447296

CC1(C)c2ccccc2-c2ccc(N(c3ccccc3)c3ccc(-c4nc(-c5ccccc5)c(-c5ccccc5)nc4-c4ccc(N(c5ccccc5)c5ccc6c(c5)C(C)(C)c5ccccc5-6)cc4)cc3)cc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 4/20 0.38
KDM4E B2RXH2 4/20 0.35
LMNA P02545 3/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
PSMB5 P28074 1/20 0.35
ALDH1A1 P00352 5/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
HTT P42858 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
HPGD P15428 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
NOX1 Q9Y5S8 1/20 0.32
ADK P55263 2/20 0.32
GAA P10253 1/20 0.31
PDE10A Q9Y233 1/20 0.31
KMT2A Q03164 1/20 0.31
ATM Q13315 1/20 0.31
TLR9 Q9NR96 1/20 0.31
THRB P10828 1/20 0.31
MLNR O43193 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14447291 0.93 KDM4E (0.37) PDK2KDM4ELMNASMN1; SMN2PSMB5
SCHEMBL12146661 0.92 TDP1 (0.43) KDM4ELMNASMN1; SMN2PSMB5ALDH1A1
SCHEMBL12690749 0.91 TDP1 (0.39) PDK2KDM4ELMNASMN1; SMN2PSMB5
SCHEMBL12146660 0.91 TDP1 (0.42) KDM4ELMNASMN1; SMN2PSMB5ALDH1A1
SCHEMBL14270744 0.90 PDK2 (0.42) PDK2KDM4ELMNASMN1; SMN2ALDH1A1
SCHEMBL15081595 0.90 PDK2 (0.42) PDK2KDM4ELMNASMN1; SMN2ALDH1A1
SCHEMBL14036996 0.90 PDK2 (0.42) PDK2KDM4ELMNASMN1; SMN2ALDH1A1
SCHEMBL20707495 0.90 PDK2 (0.42) PDK2KDM4ELMNASMN1; SMN2ALDH1A1
SCHEMBL16158299 0.90 PDK2 (0.42) PDK2KDM4ELMNASMN1; SMN2ALDH1A1
SCHEMBL18926277 0.90 PDK2 (0.42) PDK2KDM4ELMNASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9324951-B2 Pyrazine derivative, and light emitting element, display device, electronic device using the pyrazine derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2016-04-26 US disclosed
US-9324951-B2 Pyrazine derivative, and light emitting element, display device, electronic device using the pyrazine derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2016-04-26 US disclosed
US-20150112065-A1 Pyrazine Derivative, and Light Emitting Element, Display Device, Electronic Device Using the Pyrazine Derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2015-04-23 US disclosed
US-20150112065-A1 Pyrazine Derivative, and Light Emitting Element, Display Device, Electronic Device Using the Pyrazine Derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2015-04-23 US disclosed
US-8920941-B2 Pyrazine derivative, and light emitting element, display device, electronic device using the pyrazine derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-12-30 US disclosed
US-8920941-B2 Pyrazine derivative, and light emitting element, display device, electronic device using the pyrazine derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-12-30 US disclosed
US-20070161793-A1 Pyrazine derivative, and light emitting element, display device, electronic device using the pyrazine derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2007-07-12 US disclosed
US-20070161793-A1 Pyrazine derivative, and light emitting element, display device, electronic device using the pyrazine derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2007-07-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070161793-A1 Pyrazine derivative, and light emitting element, display device, electronic device using the pyrazine derivative GRIA1, GRIN1, GRIA2 PDK2 107/4885KDM4E 4164/4885LMNA 3768/4885
US-20150112065-A1 Pyrazine Derivative, and Light Emitting Element, Display Device, Electronic Device Using the Pyrazine Derivative GRIA1, GRIN1, GRIA2 PDK2 107/4885KDM4E 4164/4885LMNA 3768/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.